Individualised treatment targets for elderly patients with type 2 diabetes using vildagliptin add-on or lone therapy (INTERVAL): a 24 week, randomised, double-blind, placebo-controlled study
Strain, W David, Dr, Lukashevich, Valentina, MD, Kothny, Wolfgang, MD, Hoellinger, Marie-José, MD, Paldánius, Päivi Maria, MMedSci
Published in The Lancet (British edition) (03.08.2013)
Published in The Lancet (British edition) (03.08.2013)
Get full text
Journal Article